EMEA-000488-PIP02-11 - paediatric investigation plan

Rubidium (82Rb) chloride

Key facts

• Active Substance:
  Rubidium (82Rb) chloride
• Therapeutic area:
  Diagnostic
• Decision number:
  P/0052/2012
• PIP number:
  EMEA-000488-PIP02-11
• Pharmaceutical form(s):
  Radionuclide generator
• Condition(s) / indication(s):
  Visualisation of myocardial perfusion for diagnostic purposes
• Route(s) of administration:
  Intravenous use
• Contact for public enquiries:

  Advanced Accelerator Applications

  [e-mail]; Country: France; Phone: [phone]; Fax: [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  23/03/2012

Decision

P/0052/2012: EMA decision of 23 March 2012 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for rubidium (82Rb) chloride (EMEA-000488-PIP02-11)

AdoptedReference Number: EMA/108295/2012